Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong

References

• Heininger U, Seward JF. Varicella. Lancet 2006;368: 1365–76.
   PubMed Web of Science ®Google Scholar
• Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995; 172:706–12.
   PubMed Web of Science ®Google Scholar
• Macartney K, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Acute Respiratory Infections Group. Cochrane Database Syst Rev 2008;(3): CD001833.
   Google Scholar
• Hong Kong childhood immunisation programme 2012. Hong Kong: Centre for Health Protection;. Available at: http://www.chp.gov.hk/en/faq_dtl/9/117/16150.html (accessed 4 November 2012).
   Google Scholar
• Chan YC, Kwan YW, Chow CB, Leung CW. Hospitalisations for varicella among children and adolescents in a tertiary referral hospital in Hong Kong, 2004 to 2008. The Hong Kong Journal of Paediatrics (New Series) 2010;15:116–25.
   Web of Science ®Google Scholar
• Strutton DR, Stang PE. Prophylaxis against respiratory syncytial virus (RSV), varicella, and pneumococcal infections: economic-based decision-making. J Pediatr 2003;143 (5 Suppl):S157–62.
   Web of Science ®Google Scholar
• Wolleswinkel-van den Bosch JH, Speets AM, Rumke HC, Gumbs PD, Fortanier SC. The burden of varicella from a parent's perspective and its societal impact in the Netherlands: an internet survey. BMC Infect Dis 2011;11:320.
   PubMed Web of Science ®Google Scholar
• Brotons M, Campins M, Mendez L, Juste C, Rodrigo JA, Martinez X, et al. Effectiveness of varicella vaccines as postexposure prophylaxis. Pediatr Infect Dis J 2010;29:10–3.
   PubMed Web of Science ®Google Scholar
• Committee on Infectious Diseases, American Academy of Pediatrics. Varicella vaccine update. Pediatrics 2000;105 (1 Pt 1):136–41.
   PubMed Web of Science ®Google Scholar
• Banz K, Wagenpfeil S, Neiss A, Hammerschmidt T, Wutzler P. The burden of varicella in Germany: potential risks and economic impact. Eur J Health Econ 2004;5:46–53.
   PubMedGoogle Scholar
• Ross AH. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med 1962; 267:369–76.
   PubMed Web of Science ®Google Scholar
• Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 1977;59:3–7.
   PubMed Web of Science ®Google Scholar
• Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986;78:748–56.
   PubMed Web of Science ®Google Scholar
• Salzman MB, Garcia C. Postexposure varicella vaccination in siblings of children with active varicella. Pediatr Infect Dis J 1998;17:256–7.
   PubMed Web of Science ®Google Scholar
• Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, et al. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;105(1 Pt 1):84–8.
   PubMed Web of Science ®Google Scholar
• Mor M, Harel L, Kahan E, Amir J. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting—a pilot study. Vaccine 2004;23:325–8.
   PubMed Web of Science ®Google Scholar
• Service guides of Hospital Authority, Hong Kong. Available at: http://www.ha.org.hk (accessed 15 April 2013).
   Google Scholar
• Bilcke J, Ogunjimi B, Marais C, De Smet F, Callens M, Callaert K, et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 2012;140:2096–109.
   Google Scholar
• Brisson M, Edmunds WJ. Varicella vaccination in England and Wales: cost–utility analysis. Arch Dis Child 2003; 88:862–9.
   PubMed Web of Science ®Google Scholar
• Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russel LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253–8.
   PubMed Web of Science ®Google Scholar
• Coudeville L, Paree F, Lebrum T, Sailly JC. The value of varicella vaccination in healthy children: cost–benefit analysis of the situation in France. Vaccine 1999;17:142–51.
   PubMed Web of Science ®Google Scholar
• Fornaro P, Gandini F, Marin M, Pedrazzi C, Piccoli P, Tognetti D, et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases. Pediatr Infect Dis J 1999;18:414–9.
   PubMed Web of Science ®Google Scholar
• Scuffham P, Devlin N, Eberhart-Philips J, Wilson-Salt R. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunization schedule. Soc Sci Med 1999;49:763–79.
   PubMed Web of Science ®Google Scholar
• Beutels P, Clara R, Tormans G, Doorslaer V, Van Damme P. Costs and benefits of routine varicella vaccination in German children. J Infect Dis 1996;174(Suppl 3):S335–41.
   Google Scholar
• Diez Domingo J, Ridao M, Latour J, Ballester A, Morant A. A cost–benefit analysis of routine varicella vaccination in Spain. Vaccine 1999;17:1306–11.
   PubMed Web of Science ®Google Scholar
• Lieu TA, Cochi SL, Black SB, Halloran ME, Shinefield HR, Holmes SJ, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994;271: 375–81.
   PubMed Web of Science ®Google Scholar
• Shinjoh M, Takahashi T. Varicella zoster exposure on paediatric wards between 2000 and 2007: safe and effective post-exposure prophylaxis with oral aciclovir. J Hosp Infect 2009; 72:163–8.
   PubMed Web of Science ®Google Scholar
• Ferson MJ. Varicella vaccine in post-exposure prophylaxis. Commun Dis Intell 2001;25:13–5.
   PubMedGoogle Scholar
• Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S, et al. PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child 2011; 96:841–5.
   PubMed Web of Science ®Google Scholar
• Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, et al. Economic evaluation of varicella vaccination: results of a systematic review. Hum Vaccin Immunother 2013;9. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar